| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10x Genomics, Inc. (TXG) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 32 sells. TXG is classified in the Health Care Technology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.07M | $33.81M | - | |
| Other | 432.6K | $13.65M | - | |
| Dir | 368.4K | $11.62M | - | |
| CFO | 297.4K | $9.38M | - | |
| Dir | 85.9K | $2.71M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2020 | McAnear Justin J.84 | Chief Financial Officer | Sale+OE | 10,000 | $99.34 | $993,430.44 | -48.2% | |
| Aug 3, 2020 | Hindson Benjamin J.82 | See Remarks | Sale+OE | 33,750 | $99.34 | $3,352,687.26 | -10.1% | |
| Aug 3, 2020 | Crutchfield Bradford87 | Chief Commercial Officer | Sale+OE | 17,000 | $99.33 | $1,688,606.48 | -55.5% | |
| Aug 3, 2020 | Stuelpnagel John R89 | Director | Sell | 7,500 | $99.34 | $745,046.59 | -0.4% | |
| Aug 3, 2020 | Saxonov Serge80 | Chief Executive Officer | Sale+OE | 10,000 | $99.33 | $993,275.64 | -0.3% | |
| Jul 16, 2020 | Stuelpnagel John R89 | Director | Sell | 7,500 | $88.86 | $666,426.52 | -0.4% | |
| Jul 1, 2020 | Stuelpnagel John R89 | Director | Sell | 7,500 | $87.58 | $656,813.19 | -0.4% | |
| Jul 1, 2020 | McAnear Justin J.84 | Chief Financial Officer | Sale+OE | 10,000 | $87.60 | $875,997.42 | -66.8% | |
| Jul 1, 2020 | Hindson Benjamin J.82 | See Remarks | Sale+OE | 33,750 | $87.60 | $2,956,607.22 | -13.1% | |
| Jul 1, 2020 | Crutchfield Bradford87 | Chief Commercial Officer | Sale+OE | 17,000 | $87.60 | $1,489,135.67 | -63.2% |